BioRestorative Therapies (BRTX) Net Shares Issued and Repurchased (2015 - 2025)

BioRestorative Therapies (BRTX) has reported Net Shares Issued and Repurchased for 10 consecutive years, with $2.2 million the latest figure, recorded in Q4 2025.

• For the quarter ending Q4 2025, Net Shares Issued and Repurchased rose 13.86% year-over-year to $2.2 million; the trailing twelve-month figure through Dec 2025 stood at $2.2 million (up 13.86% YoY), and the FY2025 full-year result was $2.2 million, up 13.86% from the prior year.
• Net Shares Issued and Repurchased rose to $2.2 million in Q4 2025 per BRTX's latest filing, from $2.2 million in the prior quarter.
• Across five years, Net Shares Issued and Repurchased topped out at $2.2 million in Q4 2025 and bottomed at $25000.0 in Q1 2022.
• Historically, Net Shares Issued and Repurchased has averaged $1.1 million across 5 years, with a median of $733783.5 in 2021.
• The sharpest annual moves came in 2021 and 2022: Net Shares Issued and Repurchased jumped 16770900.0% in 2021, then slumped 97.02% in 2022.
• Over 5 years, Net Shares Issued and Repurchased stood at $838550.0 in 2021, then plunged by 97.02% to $25000.0 in 2022, then surged by 2416.07% to $629017.0 in 2023, then soared by 207.58% to $1.9 million in 2024, then gained by 13.86% to $2.2 million in 2025.
• According to Business Quant data, Net Shares Issued and Repurchased over the past three periods registered $2.2 million, $2.2 million, and $1.9 million for Q4 2025, Q1 2025, and Q4 2024 respectively.